We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





DVD Technology-Based System Quickly and Inexpensively Detects SARS-CoV-2 Antigens and Specific Antibodies

By LabMedica International staff writers
Posted on 10 Feb 2021
A new DVD technology-based system quickly and inexpensively detects SARS-CoV-2 antigens and specific antibodies.

Researchers from the Polytechnic University of Valencia (Valencia, Spain) have developed a new system at laboratory scale that allows a rapid, cheap and effective detection of COVID-19. More...
The system consists of a biosensor based on DVD technologies, that detects specific antibodies (G, M and A) and SARS-CoV-2 antigens - differentiating them to those of influenza - in a safe way, in less than 30 minutes, by analyzing serum or saliva samples. The price of the test is estimated at less than two Euros.

Called COMBO-SARS-CoV-2, the system can analyze up to a total of six serum and saliva samples simultaneously, determining type G, M and A antibodies and virus-specific antigens in less than half an hour. When a patient tests positive, the serological and/or saliva sample generates an optical signal that allows the identification of individuals who have suffered or are suffering the infection and establishes the concentration of the specific biomarkers. The COMBO-SARS-CoV-2 system can also be applied to detect other agents with infective capacity such as influenza viruses, adenoviruses and respiratory syncytial virus.

“The developed system will allow a rapid and automated viral diagnosis, at a much lower cost than the kits currently in use. Furthermore, these biosensors will enable a practical and efficient monitoring of the level of neutralizing antibodies once the vaccine is ready,” said Sergi Morais, Professor in the Department of Chemistry.

Related Links:
Polytechnic University of Valencia


Gold Member
SARS-CoV-2 Reactive & Non-Reactive Controls
Qnostics SARS-CoV-2 Typing
Online QC Software
Acusera 24•7
POC Immunoassay Analyzer
Procise DX
New
Portable POCT Blood Gas Analyzer
BD100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Illustration of the new blood test, which uses a DNA chip to detect the tumor’s biological fingerprint (Photo courtesy of Tel Aviv University)

Blood Test on a Chip Offers Low-Cost Lung Cancer Detection Without DNA Sequencing

Lung cancer is the leading cause of cancer deaths worldwide, and screening often yields indeterminate results that prompt invasive workups. Computed tomography (CT) detects small nodules but can flag benign... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Whole-Cell Genomic Analysis Expands the Potential of Liquid Biopsy

Liquid biopsy has expanded access to tumor genomics, but most blood-based assays rely on short, degraded fragments of cell-free circulating tumor DNA (ctDNA). Isolating intact circulating tumor cells from... Read more

Microbiology

view channel
Image: An innovative countywide program in Taiwan combines risk-based screening with decentralized community care to improve hepatitis C detection and treatment (Image Credit: iStock)

Precision Screening Helps Close Hepatitis C Diagnosis and Treatment Gaps

Hepatitis C remains a leading cause of cirrhosis and liver cancer, yet many infections go undiagnosed or untreated because health systems fail to reach those at greatest risk. Although highly effective... Read more

Pathology

view channel
Image: Through the PCCP, Proscia gains a more efficient pathway to expand Concentriq AP-Dx interoperability while maintaining regulatory oversight (Photo courtesy of Proscia)

FDA-Cleared Digital Pathology Platform Expands Interoperability for Primary Diagnosis

Rising cancer incidence is colliding with a shrinking pathologist workforce, intensifying pressure on diagnostic turnaround times in clinical laboratories. Many labs are adopting digital pathology to manage... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.